46 results
8-K
EX-10.3
ADAP
Adaptimmune Therapeutics Plc
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
Hawser Way, Randolph, NJ, 07869 (the "Supplier"); and
Adaptimmune LLC a Delaware company with principal address at 351 Rouse Boulevard, Philadelphia … , PA19112 (the "Client").
Background:
This Variation Agreement amends the supplier services agreement dated 30 September 2019 between the Company
8-K
EX-10.2
ADAP
Adaptimmune Therapeutics Plc
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
2020 or such other date as the Company and the Supplier/Consultant may agree in writing.”
As from 1 April 2020, the Services in the Assignment
8-K
EX-99.1
4p9nsvx1kdz9 fr
27 Feb 19
Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
7:43am
8-K/A
EX-99.1
moqe43c6wpre ieh3e
27 Feb 19
CORRECTING and REPLACING — Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
5:16pm
8-K
EX-10.2
afeg 76mu833t
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
EX-14.1
ttvhdr0esapulg6z28
24 Jul 17
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
12:00am
10-K
EX-10.21
ukygv
13 Mar 17
Annual report
12:00am
8-K
EX-10.4
hfgjbm3f er4xh3b
27 Jun 19
Departure of Directors or Certain Officers
8:08am
8-K
EX-10.01
m794klg z8m5fkxl
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am
8-K
EX-10.1
c87osk9e
27 Feb 24
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company’s Sarcoma Franchise
8:13am
20-F
EX-4.12
xvrhh8h6
13 Oct 15
Annual report (foreign)
12:00am